CAD 5.51
(0.18%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -2.56 Million | 17.56 Million | 25.02 Million | 74.68 Million | 25.64 Million | 10.37 Million |
Net Income | -6.19 Million | -9.26 Million | 33.08 Million | 42.79 Million | 10.09 Million | -4.01 Million |
Depreciation & Amortization | 3.87 Million | 4.53 Million | 5.04 Million | 4.45 Million | 10.17 Million | 19.79 Million |
Deferred income taxes | -2.94 Million | -3.08 Million | 13.03 Million | 18.66 Million | 4.21 Million | 601 Thousand |
Stock-based compensation | 1.37 Million | 1.53 Million | 2.4 Million | 2.41 Million | 1.81 Million | 1.7 Million |
Change in working capital | 636 Thousand | 16.84 Million | -16.43 Million | 8.6 Million | -2.15 Million | 6.31 Million |
Other non-cash items | 691 Thousand | 7 Million | -12.11 Million | -2.25 Million | 1.5 Million | -14.02 Million |
Investing Cash Flow | -799 Thousand | -1.08 Million | -2.87 Million | -1.82 Million | -1.93 Million | -13 Thousand |
Investments in PPE | -1.03 Million | -1.17 Million | -3.02 Million | -1.82 Million | -2.06 Million | -423 Thousand |
Acquisitions | - | - | 147 Thousand | - | 135 Thousand | 410 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 231 Thousand | 95 Thousand | -1.44 Million | -189 Thousand | 175 Thousand | - |
Financing Cash Flow | -445 Thousand | -30.42 Million | -94.05 Million | -15.19 Million | -18.96 Million | -12.11 Million |
Debt repayment | -1.54 Million | -1.73 Million | -1.54 Million | -1.35 Million | -172 Thousand | -392 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -11 Thousand | -28.74 Million | -97.79 Million | -16.96 Million | -20.2 Million | -3.26 Million |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 1.11 Million | 52 Thousand | 5.28 Million | 3.12 Million | 1.41 Million | -8.45 Million |
Accounts receivables | 4.99 Million | 26.74 Million | -15.36 Million | 5.92 Million | -12.51 Million | 8.05 Million |
Accounts payables | -2.51 Million | -9.93 Million | 2.32 Million | 143 Thousand | 9.74 Million | -1.51 Million |
Inventory | -4.99 Million | -26.74 Million | 15.36 Million | -5.92 Million | 12.51 Million | - |
Other working capital | 3.15 Million | 26.78 Million | -18.76 Million | 8.46 Million | -11.9 Million | 7.83 Million |
Cash at beginning of period | 46.14 Million | 60.21 Million | 129.15 Million | 71.68 Million | 68.04 Million | 71.63 Million |
Cash at end of period | 42.34 Million | 46.14 Million | 60.21 Million | 129.15 Million | 71.68 Million | 68.04 Million |
Capital Expenditure | -1.03 Million | -1.17 Million | -3.02 Million | -1.82 Million | -2.06 Million | -423 Thousand |
Effect of forex changes on cash | 7000.00 | -134 Thousand | 2.96 Million | -188 Thousand | -1.11 Million | -1.83 Million |
Net cash flow / Change in cash | -3.8 Million | -14.07 Million | -68.94 Million | 57.47 Million | 3.63 Million | -3.58 Million |
Free Cash Flow | -3.59 Million | 16.39 Million | 21.99 Million | 72.86 Million | 23.57 Million | 9.94 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 1.69 Million | 2.07 Million | -3.59 Million | -6.19 Million | 1.62 Million | -619 Thousand |
Depreciation & Amortization | 761 Thousand | 804 Thousand | 839 Thousand | 3.87 Million | 873 Thousand | 963 Thousand |
Deferred income taxes | 193 Thousand | -198 Thousand | -612 Thousand | -2.94 Million | -106 Thousand | -214 Thousand |
Stock-based compensation | 407 Thousand | 358 Thousand | 818 Thousand | 1.37 Million | 288 Thousand | 296 Thousand |
Change in working capital | -6.16 Million | -1.07 Million | 3.72 Million | 636 Thousand | -3.31 Million | -1.68 Million |
Other non-cash items | 90 Thousand | 95 Thousand | 1.35 Million | 691 Thousand | 604 Thousand | 1.97 Million |
Investing Cash Flow | 14 Thousand | 5000.00 | 30 Thousand | -799 Thousand | -174 Thousand | -285 Thousand |
Investments in PPE | -139 Thousand | -147 Thousand | -121 Thousand | -1.03 Million | -201 Thousand | -354 Thousand |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 153 Thousand | 152 Thousand | 151 Thousand | 231 Thousand | 27 Thousand | 69 Thousand |
Financing Cash Flow | 481 Thousand | -362 Thousand | -484 Thousand | -445 Thousand | 201 Thousand | 96 Thousand |
Debt repayment | -357 Thousand | -362 Thousand | -484 Thousand | -1.54 Million | -375 Thousand | -378 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | -11 Thousand | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 838 Thousand | - | 484 Thousand | 1.11 Million | 576 Thousand | 474 Thousand |
Accounts receivables | -4.2 Million | -4.02 Million | 5.41 Million | 4.99 Million | -2.72 Million | -254 Thousand |
Accounts payables | -573 Thousand | 2.45 Million | -1.57 Million | -2.51 Million | -1.67 Million | 590 Thousand |
Inventory | - | - | -5.41 Million | -4.99 Million | 2.72 Million | 254 Thousand |
Other working capital | -36 Thousand | -1.15 Million | 5.29 Million | 3.15 Million | -1.64 Million | -2.27 Million |
Cash at beginning of period | 44.37 Million | 45.1 Million | 42.34 Million | 46.14 Million | 42.53 Million | 41.83 Million |
Cash at end of period | 41.38 Million | 44.37 Million | 45.1 Million | 42.34 Million | 42.34 Million | 42.53 Million |
Capital Expenditure | -139 Thousand | -147 Thousand | -121 Thousand | -1.03 Million | -201 Thousand | -354 Thousand |
Effect of forex changes on cash | -141 Thousand | -284 Thousand | 267 Thousand | 7000.00 | -192 Thousand | 171 Thousand |
Net cash flow / Change in cash | -2.98 Million | -730 Thousand | 2.76 Million | -3.8 Million | -194 Thousand | 703 Thousand |
Free Cash Flow | -3.48 Million | -236 Thousand | 2.4 Million | -3.59 Million | -230 Thousand | 367 Thousand |
RCR
0MV8
4175
NGENIC
TEPCF
AGM-PG